Goldman Sachs’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.1M | Buy |
1,591,945
+327,898
| +26% | +$9.74M | ﹤0.01% | 2020 |
|
|
2025
Q4 | $39.3M | Buy |
1,264,047
+499,485
| +65% | +$13.7M | 0.01% | 1709 |
|
|
2025
Q3 | $16.5M | Sell |
764,562
-135,263
| -15% | -$2.44M | ﹤0.01% | 2452 |
|
|
2025
Q2 | $12.6M | Sell |
899,825
-331,267
| -27% | -$4.5M | ﹤0.01% | 2551 |
|
|
2025
Q1 | $16.6M | Buy |
1,231,092
+310,998
| +34% | +$5.3M | ﹤0.01% | 2203 |
|
|
2024
Q4 | $17.6M | Buy |
920,094
+180,841
| +24% | +$3.93M | ﹤0.01% | 2254 |
|
|
2024
Q3 | $16.8M | Sell |
739,253
-260,688
| -26% | -$4.26M | ﹤0.01% | 2220 |
|
|
2024
Q2 | $13M | Buy |
999,941
+456,801
| +84% | +$6.32M | ﹤0.01% | 2261 |
|
|
2024
Q1 | $9.51M | Buy |
543,140
+161,403
| +42% | +$3.13M | ﹤0.01% | 2501 |
|
|
2023
Q4 | $8.31M | Sell |
381,737
-17,543
| -4% | -$277K | ﹤0.01% | 2701 |
|
|
2023
Q3 | $6.12M | Buy |
399,280
+83,723
| +27% | +$1.6M | ﹤0.01% | 2814 |
|
|
2023
Q2 | $7.51M | Sell |
315,557
-39,353
| -11% | -$1.01M | ﹤0.01% | 2729 |
|
|
2023
Q1 | $9.03M | Buy |
354,910
+111,236
| +46% | +$3.57M | ﹤0.01% | 2512 |
|
|
2022
Q4 | $7.12M | Sell |
243,674
-126,054
| -34% | -$2.9M | ﹤0.01% | 2869 |
|
|
2022
Q3 | $7.58M | Buy |
+369,728
| New | +$6.65M | ﹤0.01% | 2768 |
|
|
2022
Q2 | – | Sell |
-66,598
| Closed | -$1.23M | – | 6745 |
|
|
2022
Q1 | $1.23M | Buy |
+66,598
| New | +$1.28M | ﹤0.01% | 4658 |
|
|
2020
Q4 | – | Sell |
-3,420
| Closed | -$40K | – | 5719 |
|
|
2020
Q3 | $40K | Hold |
3,420
| – | – | ﹤0.01% | 5204 |
|
|
2020
Q2 | $57K | Hold |
3,420
| – | – | ﹤0.01% | 5059 |
|
|
2020
Q1 | $23K | Sell |
3,420
-125
| -4% | -$1.46K | ﹤0.01% | 5121 |
|
|
2019
Q4 | $26K | Sell |
3,545
-14,872
| -81% | -$152K | ﹤0.01% | 5163 |
|
|
2019
Q3 | $202K | Sell |
18,417
-18,042
| -49% | -$399K | ﹤0.01% | 4823 |
|
|
2019
Q2 | $1.12M | Buy |
36,459
+31,782
| +680% | +$1.28M | ﹤0.01% | 3922 |
|
|
2019
Q1 | $196K | Buy |
4,677
+744
| +19% | +$33.7K | ﹤0.01% | 4808 |
|
|
2018
Q4 | $179K | Buy |
3,933
+1,398
| +55% | +$80.9K | ﹤0.01% | 4861 |
|
|
2018
Q3 | $212K | Sell |
2,535
-534
| -17% | -$50.4K | ﹤0.01% | 4895 |
|
|
2018
Q2 | $295K | Sell |
3,069
-1,378
| -31% | -$146K | ﹤0.01% | 4794 |
|
|
2018
Q1 | $468K | Buy |
+4,447
| New | +$483K | ﹤0.01% | 4540 |
|
|
2017
Q3 | – | Sell |
-8,146
| Closed | -$1.58M | – | 6872 |
|
|
2017
Q2 | $1.58M | Buy |
8,146
+3,823
| +88% | +$645K | ﹤0.01% | 4027 |
|
|
2017
Q1 | $807K | Buy |
+4,323
| New | +$746K | ﹤0.01% | 4577 |
|
|
2016
Q2 | – | Sell |
-54
| Closed | -$6K | – | 7274 |
|
|
2016
Q1 | $6K | Buy |
+54
| New | +$6.9K | ﹤0.01% | 6963 |
|
Other funds holding VRDN
BG
VCM
FFM
VA
PBA
